Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Publication | Open Access

DOI Full Paper Access

424

Citations

References

2009

Year

Elizabeth Poplin, Yang Feng, Jordan Berlin, Mace L. Rothenberg, Howard S. Höchster, Edith P. Mitchell, Steven R. Alberts, Peter J. O’Dwyer, Daniel G. Haller, Paul J. Catalano,

Journal of Clinical Oncology

Abstract

References